Navigation Links
Hallucinogen Gives Lasting Spiritual Boost

Psilocybin may help treat patients with cancer, depression, drug abuse, study says

WEDNESDAY, July 2 (HealthDay News) -- The spiritual effects of a substance in "sacred mushrooms" can last more than a year, Johns Hopkins researchers claim.

The scientists said their investigations may lead to new ways to help people with conditions such as cancer, depression and drug dependence.

In a previous study, the researchers gave psilocybin to 36 healthy, well-educated volunteers with active spiritual lives. After taking the substance under controlled conditions, 60 percent of the participants reported have a "full mystical experience."

When the researchers checked with the volunteers 14 months later, the same percentage said taking psilocybin increased their sense of well-being or life satisfaction.

"Most of the volunteers looked back on their experience up to 14 months later and rated it as the most, or one of the five most, personally meaningful and spiritually significant of their lives," lead investigator Roland Griffiths, a professor in the departments of psychiatry and behavioral sciences and neuroscience, said in a prepared statement.

The study was published in the current issue of the Journal of Psychopharmacology.

"This is truly remarkable finding, "Griffiths said. "Rarely in psychological research do we see such persistently positive reports from a single event in the laboratory. This gives credence to claims that the mystical-type experiences some people have during hallucinogen sessions may help patients suffering from cancer-related anxiety or depression, and may serve as a potential treatment for drug dependence. We're eager to move ahead with that research."

He noted that while some of the volunteers "reported strong fear or anxiety for a portion of their day-long psilocybin sessions, none reported any lingering harmful effects, and we didn't observe any clinical evidence of harm."

However, if hallucinogens are used in poorly supervised settings, the possible fear or anxiety responses could lead to harmful behaviors, Griffiths warned.

More information

The National Institute on Drug Abuse has more about hallucinogens.

-- Robert Preidt

SOURCE: Johns Hopkins Medical Institutions, news release, July 1, 2008

Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Brookhaven scientists explore brains reaction to potent hallucinogen
2. Spiritual effects of hallucinogens persist, Johns Hopkins researchers report
3. Online Epidemic Gives Clues to Bird Flu Spread
4. Welch Foundation gives $1.6 million for drug discovery research
5. 24 Hour Fitness Gives The Biggest Loser High-Tech Upgrade
6. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
7. Ancient mechanism for coping with stresses also gives cancer a boost
8. What gives us sunburn protects crayfish against bacteria
9. Bellevue Dentist Gives a Thumbs Up to Britney Spears Smile
10. National Trichotillomania Awareness Week Gives Help and Hope to Hair-Pullers
11. Mouse Study Gives Clues to Colitis
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. ... that the organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior ... award celebrates exceptional special needs providers that excel in synthesizing the areas of ...
(Date:12/1/2015)... ... , ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based ... sale in the United States. Clarity is a Superior Dual Wavelength Platform which ... a single platform that is easy to own and operate. , For over ...
(Date:12/1/2015)... ... December 01, 2015 , ... XTC Semifinals 2016 - ... to head to Las Vegas for CES 2016, the world’s largest Consumer Electronic Show, ... Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, and venture capitalist ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker ... order to date. , The order will be from the China Disabled Persons’ ... Implant System is an effective solution for children and adults suffering from severe ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as having ... Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. , ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation ... company specializing in oncology, today announced that it has ... company,s pivotal global Phase 3 clinical trial of aldoxorubicin ... was originally estimated to be completed in Q1 2016. The ... conducted under a Special Protocol Assessment from the FDA ...
Breaking Medicine Technology: